{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:39:18Z","timestamp":1793691558372,"version":"4.5.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Damage-associated molecular patterns (DAMPs) are a cause of Crohn\u2019s disease (CD). Peroxiredoxin 1 (Prdx1), a newly identified DAMP, plays a critical role in organ injury with its potent proinflammatory properties. However, its specific role in CD remains unclear. Here, we identify serum Prdx1 as a DAMP involved in CD. Serum Prdx1 levels were significantly increased and positively correlated with the severity of intestinal inflammation in both CD patients and mice with experimental colitis. Genetic knockout of <jats:italic>Prdx1<\/jats:italic> or administration of a Prdx1-neutralizing antibody attenuated colitis in mice, as evidenced by restoration of the colonic epithelium, improved disease activity, and reduced colonic inflammation. These protective effects were impaired by introduction of recombinant Prdx1 (rPrdx1). Mechanistically, Prdx1 exacerbated intestinal inflammation by promoting macrophage infiltration and subsequent cytokine production. Depletion of macrophages abolished the rPrdx1-mediated exacerbation of colitis. Further, rPrdx1 was internalized by macrophages, leading to lysosomal disruption and subsequent activation of the NLRP3 inflammasome. Pharmacological inhibition of NLRP3 effectively abrogated rPrdx1-induced exacerbation of colitis. In conclusion, serum Prdx1 promotes intestinal inflammation in CD at least in part by activating the NLRP3 inflammasome through lysosomal disruption in macrophages. These findings highlight the pathogenic role of Prdx1 in CD and reveal therapeutic potential of managing CD via neutralization of circulating Prdx1.<\/jats:p>","DOI":"10.1038\/s41419-025-07898-1","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T15:46:09Z","timestamp":1753544769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Peroxiredoxin 1 promotes intestinal inflammation by activating the NLRP3 inflammasome in macrophages through lysosomal disruption in Crohn\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Shenglan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuping","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7295-0089","authenticated-orcid":false,"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4707-2776","authenticated-orcid":false,"given":"Zhangzhe","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"7898_CR1","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","volume":"389","author":"J Torres","year":"2017","unstructured":"Torres J, Mehandru S, Colombel J-F, Peyrin-Biroulet L. Crohn\u2019s disease. Lancet. 2017;389:1741\u201355.","journal-title":"Lancet"},{"key":"7898_CR2","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390:2769\u201378.","journal-title":"Lancet"},{"key":"7898_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41395-018-0233-2","volume":"114","author":"SC Ng","year":"2019","unstructured":"Ng SC, Kaplan GG, Tang W, Banerjee R, Adigopula B, Underwood FE, et al. Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific. Am J Gastroenterol. 2019;114:107\u201315.","journal-title":"Am J Gastroenterol"},{"key":"7898_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","volume":"18","author":"GG Kaplan","year":"2020","unstructured":"Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020;18:56\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7898_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109265","volume":"35","author":"G Tan","year":"2021","unstructured":"Tan G, Huang C, Chen J, Chen B, Zhi F. Gasdermin-E-mediated pyroptosis participates in the pathogenesis of Crohn\u2019s disease by promoting intestinal inflammation. Cell Rep. 2021;35:109265.","journal-title":"Cell Rep"},{"key":"7898_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/mi.2016.14","volume":"9","author":"RK Boyapati","year":"2016","unstructured":"Boyapati RK, Rossi AG, Satsangi J, Ho GT. Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications. Mucosal Immunol. 2016;9:567\u201382.","journal-title":"Mucosal Immunol"},{"key":"7898_CR7","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1172\/JCI76344","volume":"125","author":"X Zhu","year":"2015","unstructured":"Zhu X, Messer JS, Wang Y, Lin F, Cham CM, Chang J, et al. Cytosolic HMGB1 controls the cellular autophagy\/apoptosis checkpoint during inflammation. J Clin Invest. 2015;125:1098\u2013110.","journal-title":"J Clin Invest"},{"key":"7898_CR8","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1097\/MIB.0000000000000938","volume":"22","author":"F Palone","year":"2016","unstructured":"Palone F, Vitali R, Cucchiara S, Mennini M, Armuzzi A, Pugliese D, et al. Fecal HMGB1 reveals microscopic inflammation in adult and pediatric patients with inflammatory bowel disease in clinical and endoscopic remission. Inflamm Bowel Dis. 2016;22:2886\u201393.","journal-title":"Inflamm Bowel Dis"},{"key":"7898_CR9","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.7150\/thno.96184","volume":"14","author":"Y Cai","year":"2024","unstructured":"Cai Y, Li S, Yang Y, Duan S, Fan G, Bai J, et al. Intestinal epithelial damage-derived mtDNA activates STING-IL12 axis in dendritic cells to promote colitis. Theranostics. 2024;14:4393\u2013410.","journal-title":"Theranostics"},{"key":"7898_CR10","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1146\/annurev-biochem-060815-014431","volume":"86","author":"SG Rhee","year":"2017","unstructured":"Rhee SG, Kil IS. Multiple functions and regulation of mammalian peroxiredoxins. Annu Rev Biochem. 2017;86:749\u201375.","journal-title":"Annu Rev Biochem"},{"key":"7898_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/antiox8060169","volume":"8","author":"Y Kim","year":"2019","unstructured":"Kim Y, Jang HH. Role of cytosolic 2-Cys Prx1 and Prx2 in redox signaling. Antioxidants. 2019;8:169.","journal-title":"Antioxidants"},{"key":"7898_CR12","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nm.2749","volume":"18","author":"T Shichita","year":"2012","unstructured":"Shichita T, Hasegawa E, Kimura A, Morita R, Sakaguchi R, Takada I, et al. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat Med. 2012;18:911\u20137.","journal-title":"Nat Med"},{"key":"7898_CR13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.bbrc.2020.04.149","volume":"527","author":"Y He","year":"2020","unstructured":"He Y, Peng Y, Tao L, Peng Z, Yang H. Peroxiredoxin-1 aggravates lipopolysaccharide-induced septic shock via promoting inflammation. Biochem Biophys Res Commun. 2020;527:861\u201365.","journal-title":"Biochem Biophys Res Commun"},{"key":"7898_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102086","volume":"46","author":"C-H Liu","year":"2021","unstructured":"Liu C-H, Huang Z-H, Huang S-C, Jou T-S. Endocytosis of peroxiredoxin 1 links sterile inflammation to immunoparalysis in pediatric patients following cardiopulmonary bypass. Redox Biol. 2021;46:102086.","journal-title":"Redox Biol"},{"key":"7898_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2019.04.012","volume":"137","author":"Y He","year":"2019","unstructured":"He Y, Li S, Tang D, Peng Y, Meng J, Peng S, et al. Circulating Peroxiredoxin-1 is a novel damage-associated molecular pattern and aggravates acute liver injury via promoting inflammation. Free Radic Biol Med. 2019;137:24\u201336.","journal-title":"Free Radic Biol Med"},{"key":"7898_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.kint.2023.04.013","volume":"104","author":"S Li","year":"2023","unstructured":"Li S, Zhang Y, Lu R, Lv X, Lei Q, Tang D, et al. Peroxiredoxin 1 aggravates acute kidney injury by promoting inflammation through Mincle\/Syk\/NF-\u03baB signaling. Kidney Int. 2023;104:305\u201323.","journal-title":"Kidney Int"},{"key":"7898_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13741","volume":"32","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wu XX, Li S, Wu JF, Han S, Lin ZJ, et al. Peroxiredoxin 1 as an inflammatory marker in diarrhea-predominant and postinfectious irritable bowel syndrome. Neurogastroenterol Motil. 2020;32:e13741.","journal-title":"Neurogastroenterol Motil"},{"key":"7898_CR18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/ibd\/izab191","volume":"28","author":"J Walldorf","year":"2022","unstructured":"Walldorf J, Porzner M, Neumann M, Joodi G, Niess JH, von Boyen G, et al. The selective 5-HT1A agonist SR57746A protects intestinal epithelial cells and enteric glia cells and promotes mucosal recovery in experimental colitis. Inflamm Bowel Dis. 2022;28:423\u201333.","journal-title":"Inflamm Bowel Dis"},{"key":"7898_CR19","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.tifs.2011.03.010","volume":"22","author":"T Langerholc","year":"2011","unstructured":"Langerholc T, Maragkoudakis PA, Wollgast J, Gradisnik L, Cencic A. Novel and established intestinal cell line models\u2014an indispensable tool in food science and nutrition. Trends Food Sci Technol. 2011;22:S11\u2013S20.","journal-title":"Trends Food Sci Technol"},{"key":"7898_CR20","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2017.044","volume":"12","author":"S Wirtz","year":"2017","unstructured":"Wirtz S, Popp V, Kindermann M, Gerlach K, Weigmann B, Fichtner-Feigl S, et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 2017;12:1295\u2013309.","journal-title":"Nat Protoc"},{"key":"7898_CR21","doi-asserted-by":"publisher","first-page":"108176","DOI":"10.1016\/j.pharmthera.2022.108176","volume":"238","author":"X Pan","year":"2022","unstructured":"Pan X, Zhu Q, Pan L-L, Sun J. Macrophage immunometabolism in inflammatory bowel diseases: From pathogenesis to therapy. Pharmacol Therapeutics. 2022;238:108176.","journal-title":"Pharmacol Therapeutics"},{"key":"7898_CR22","first-page":"737","volume":"11","author":"L Liu","year":"2017","unstructured":"Liu L, Dong Y, Ye M, Jin S, Yang J, Joosse ME, et al. The pathogenic role of NLRP3 inflammasome activation in inflammatory bowel diseases of both mice and humans. J Crohns Colitis. 2017;11:737\u201350.","journal-title":"J Crohns Colitis"},{"key":"7898_CR23","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1172\/JCI98642","volume":"128","author":"L Mao","year":"2018","unstructured":"Mao L, Kitani A, Similuk M, Oler AJ, Albenberg L, Kelsen J, et al. Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn\u2019s disease. J Clin Invest. 2018;128:1793\u2013806.","journal-title":"J Clin Invest"},{"key":"7898_CR24","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1172\/JCI128322","volume":"130","author":"L Mao","year":"2020","unstructured":"Mao L, Kitani A, Hiejima E, Montgomery-Recht K, Zhou W, Fuss I, et al. Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1\u03b2\u2013mediated colitis. J Clin Investig. 2020;130:1793\u2013807.","journal-title":"J Clin Investig"},{"key":"7898_CR25","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.7150\/thno.81571","volume":"13","author":"W Zhou","year":"2023","unstructured":"Zhou W, Zhang H, Huang L, Sun C, Yue Y, Cao X, et al. Disulfiram with Cu2+ alleviates dextran sulfate sodium-induced ulcerative colitis in mice. Theranostics. 2023;13:2879\u201395.","journal-title":"Theranostics"},{"key":"7898_CR26","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JPY. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477\u201389.","journal-title":"Nat Rev Immunol"},{"key":"7898_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","volume":"48","author":"J Xu","year":"2023","unstructured":"Xu J, N\u00fa\u00f1ez G. The NLRP3 inflammasome: activation and regulation. Trends Biochem Sci. 2023;48:331\u201344.","journal-title":"Trends Biochem Sci"},{"key":"7898_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nm.4312","volume":"23","author":"T Shichita","year":"2017","unstructured":"Shichita T, Ito M, Morita R, Komai K, Noguchi Y, Ooboshi H, et al. MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1. Nat Med. 2017;23:723\u201332.","journal-title":"Nat Med"},{"key":"7898_CR29","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.immuni.2018.08.016","volume":"49","author":"M Deng","year":"2018","unstructured":"Deng M, Tang Y, Li W, Wang X, Zhang R, Zhang X, et al. The endotoxin delivery protein HMGB1 mediates caspase-11-dependent lethality in sepsis. Immunity. 2018;49:740\u201353.e7.","journal-title":"Immunity"},{"key":"7898_CR30","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/ecco-jcc\/jjx016","volume":"11","author":"H Melhem","year":"2017","unstructured":"Melhem H, Spalinger MR, Cosin-Roger J, Atrott K, Lang S, Wojtal KA, et al. Prdx6 deficiency ameliorates DSS Colitis: relevance of compensatory antioxidant mechanisms. J Crohn\u2019s Colitis. 2017;11:871\u201384.","journal-title":"J Crohn\u2019s Colitis"},{"key":"7898_CR31","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41573-024-00953-0","volume":"23","author":"S Honap","year":"2024","unstructured":"Honap S, Jairath V, Danese S, Peyrin-Biroulet L. Navigating the complexities of drug development for inflammatory bowel disease. Nat Rev Drug Discov. 2024;23:546\u201362.","journal-title":"Nat Rev Drug Discov"},{"key":"7898_CR32","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1093\/ecco-jcc\/jjab031","volume":"15","author":"M Ackermann","year":"2021","unstructured":"Ackermann M, Mucci A, McCabe A, Frei S, Wright K, Snapper SB, et al. Restored macrophage function ameliorates disease pathophysiology in a mouse model for IL10 receptor-deficient very early onset inflammatory bowel disease. J Crohn\u2019s Colitis. 2021;15:1588\u201395.","journal-title":"J Crohn\u2019s Colitis"},{"key":"7898_CR33","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.7150\/thno.95749","volume":"14","author":"Y Gao","year":"2024","unstructured":"Gao Y, Liu K-Y, Xiao W, Xie X, Liang Q, Tu Z, et al. Aryl hydrocarbon receptor confers protection against macrophage pyroptosis and intestinal inflammation through regulating polyamine biosynthesis. Theranostics. 2024;14:4218\u201339.","journal-title":"Theranostics"},{"key":"7898_CR34","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.4049\/jimmunol.1700796","volume":"201","author":"W Liu","year":"2018","unstructured":"Liu W, Guo W, Zhu Y, Peng S, Zheng W, Zhang C, et al. Targeting peroxiredoxin 1 by a curcumin analogue, AI-44, inhibits NLRP3 inflammasome activation and attenuates lipopolysaccharide-induced sepsis in mice. J Immunol. 2018;201:2403\u201313.","journal-title":"J Immunol"},{"key":"7898_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","volume":"13","author":"C Maaser","year":"2019","unstructured":"Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohn\u2019s Colitis. 2019;13:144\u201364.","journal-title":"J Crohn\u2019s Colitis"},{"key":"7898_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ecco-jcc\/jjy114","volume":"13","author":"A Sturm","year":"2019","unstructured":"Sturm A, Maaser C, Calabrese E, Annese V, Fiorino G, Kucharzik T, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects. J Crohn\u2019s Colitis. 2019;13:273\u201384.","journal-title":"J Crohn\u2019s Colitis"},{"key":"7898_CR37","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1038\/nprot.2006.446","volume":"1","author":"C Becker","year":"2006","unstructured":"Becker C, Fantini MC, Neurath MF. High resolution colonoscopy in live mice. Nat Protoc. 2006;1:2900\u20134.","journal-title":"Nat Protoc"},{"key":"7898_CR38","doi-asserted-by":"publisher","first-page":"21616","DOI":"10.1074\/jbc.M116.733410","volume":"291","author":"T Zhang","year":"2016","unstructured":"Zhang T, Xue L, Li L, Tang C, Wan Z, Wang R, et al. BNIP3 protein suppresses PINK1 kinase proteolytic cleavage to promote mitophagy. J Biol Chem. 2016;291:21616\u201329.","journal-title":"J Biol Chem"},{"key":"7898_CR39","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.cell.2016.04.015","volume":"165","author":"SK Vanaja","year":"2016","unstructured":"Vanaja SK, Russo AJ, Behl B, Banerjee I, Yankova M, Deshmukh SD, et al. Bacterial outer membrane vesicles mediate cytosolic localization of LPS and caspase-11 activation. Cell. 2016;165:1106\u201319.","journal-title":"Cell"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07898-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07898-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07898-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T02:27:11Z","timestamp":1757298431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07898-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7898"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07898-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research protocols for human serum and intestinal samples conformed to the guidelines of the Medical Ethics Committee of Xiangya Hospital, Central South University (Approval No. 201803490). Written informed consent was obtained from all study participants. All animal experimental protocols and procedures were approved by the Ethics Review Committee for Animal Experimentation of Central South University (Approval No. 202103597).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"565"}}